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Obesity and type 2 diabetes are risk factors of Alzheimer’s disease (AD). We reported that a
high fat diet (HFD) promotes amyloid precursor protein (APP) cleavage by β-site APP cleav-
ing enzyme 1 (BACE1) without increasing BACE1 levels in APP transgenic mice. However,
the detailed mechanism had remained unclear. Here we demonstrate that HFD promotes
BACE1/Adaptor protein-2 (AP-2)/clathrin complex formation by increasing AP-2 levels in
APP transgenic mice. In Swedish APP overexpressing Chinese hamster ovary (CHO) cells
as well as in SH-SY5Y cells, overexpression of AP-2 promoted the formation of BACE1/AP-
2/clathrin complex, increasing the level of the soluble form of APP β (sAPPβ). On the other
hand, mutant D495R BACE1, which inhibits formation of this trimeric complex, was shown
to decrease the level of sAPPβ. Overexpression of AP-2 promoted the internalization of
BACE1 from the cell surface, thus reducing the cell surface BACE1 level. As such, we con-
cluded that HFD may induce the formation of the BACE1/AP-2/clathrin complex, which is
followed by its transport of BACE1 from the cell surface to the intracellular compartments.
These events might be associated with the enhancement of β-site cleavage of APP in APP
transgenic mice. Here we present evidence that HFD, by regulation of subcellular trafficking
of BACE1, promotes APP cleavage.
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Introduction
Characteristic of Alzheimer’s disease (AD) pathology is formation of the amyloid plaque. The
amyloid plaque is composed of β-amyloid (Aβ), a peptide fragment of the amyloid precursor
protein (APP) produced when cleaved in sequence by β- and γ-secretase. β-secretase cleaves
APP at the extramembrane domain, producing the soluble form of APP β (sAPPβ) and the
APP C-terminus fragment β (APP-CTFβ). γ-Secretase subsequently cleaves APP-CTFβ at the
intramembrane domain, producing Aβ and the APP intracellular domain (AICD). Many
familial AD mutations have been located on the gene responsible for APP [1–3], and by taking
advantage of these pathogenic mutations, many strains of APP transgenic mice have been
established for use as AD model mice [4–6]. β-site APP cleaving enzyme 1 (BACE1) is classi-
fied as a β-secretase [7, 8] and a significant increase in BACE1 activity has been reported in
sporadic AD brains [9]. BACE1 activity is regulated by its subcellular trafficking and/or inter-
acting proteins (reviewed in [10, 11]). The first step in Aβ production is the cleavage of APP by
BACE1, thus making BACE1 a therapeutic and/or preventive target in AD research.
Obesity and type 2 diabetes are known to be risk factors of AD [12–14]. An epidemiological
study suggested that individuals following diets with high caloric intake have a 1.5 times greater
risk of AD than those with low caloric intake [15]. Moreover, many reports have shown that
the application of high fat diet (HFD) in APP transgenic mice increases Aβ deposition [16–20].
Some reports demonstrated that HFD inhibits Aβ degradation and/or clearance [17, 18], while
others argued that HFD promotes Aβ production [16, 20]. Drawing on a proposed mechanism
for the latter, some groups suggested that HFD increases the expression level of BACE1 [21–
23]. However, we have previously reported that HFD increases the level of APP-CTFβ without
changing APP or BACE1 levels, indicating that HFD may strengthen the activity of BACE1,
followed by promotion of the cleavage of APP [20], rather than increasing the BACE1 protein
level. How HFD promotes the cleavage of APP by BACE1 has remained unclear until now.
Here we demonstrate that HFD promoted the formation of BACE1/Adaptor protein-2 (AP-2)/
clathrin complex by increasing AP-2 levels in APP transgenic mice. In Swedish APP overexpres-
sing Chinese hamster ovary (CHO) cells as well as in SH-SY5Y cells, promotion of BACE1/AP-2/
clathrin complex formation by AP-2 overexpression increased the level of sAPPβ. Conversely, dis-
ruption of the complex using an artificial BACE1mutation (D495R BACE1) decreased the level of
sAPPβ. Overexpression of AP-2 promoted the internalization of BACE1 from the cell surface, and
it reduced the level of cell surface BACE1. Moreover, D495R BACE1mainly localized at the cell
surface but wild type (WT) BACE1 did within clathrin vesicles. Therefore, we concluded that HFD
might induce the formation of BACE1/AP-2/clathrin complex, thus transporting BACE1 from the
cell surface to the intracellular compartments. Our results show that this leads to enhancement of
the β-site cleavage of APP in APP transgenic mice. These results present strong evidence that
HFD, by the regulation of subcellular trafficking of BACE1, may promote its cleavage of APP.
Material and Methods
Ethics statement
All animal experiments in this study were performed with the approval of the Animal Experi-
ment Committees of Kyoto University, Graduate School of Medicine (Permit Number: 14521).
All experiments were in strict accordance with the relevant international guidelines and all
efforts were made to minimize suffering.
Animals and dietary condition
APP transgenic mice overexpressing familial mutations bearing both Swedish (K670N/M671L)
and Indiana (V717F) mutation were imported from the Jackson Laboratory (USA). They were
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maintained as heterozygotes. Age-matched APP transgenic mice were either exposed to stan-
dard diet (10% fat, 70% carbohydrate, and 20% protein, Oriental Yeast Co., Ltd., Japan) or to
HFD (caloric composition, 60% fat, 20% carbohydrate, and 20% protein, Research Diet, Inc.,
Canada) for 20 weeks (5 months), from 2–3 to 7–8 months of age. After dietary manipulation,
mice were deeply anesthetized by tribromoethanol, and transcardially fixed by 4% paraformal-
dehyde, followed by perfusion with PBS, and then brains were extracted. Extracted brains were
cut sagittally into left and right hemispheres. The left hemisphere was re-fixed in 4% parafor-
maldehyde for histological analysis. After removing the olfactory lobe and the cerebellum, the
right hemisphere was rapidly frozen in liquid nitrogen for biochemical analysis.
Cell culture and transfection
CHO cells stably overexpressing Swedish mutant APP (K670M/ N770L) (APPsw/Ncad-CHO
cells), in which it is possible to quantify released Aβ, were obtained [24] and maintained as
described previously [25, 26]. SH-SY5Y cells which derived from human neuroblastoma were
maintained in Opti-MEM (Life technology, USA) containing 10% FBS. For transient transfec-
tion into the CHO cells as well as into SH-SY5Y cells, we used TransFectin reagent (Bio-Rad,
USA) according to the manufacturer’s protocol. Reporter gene activity was assayed from 24 to
48 hours after transfection.
Immunoprecipitation and proteomics
The cerebrum of our mice was extracted in radio-immunoprecipitation assay (RIPA) buffer (50
mM Tris-HCl, 150 mMNaCl, 1% Triton X100, 1% NP-40, 0.5% Deoxycholate, 0.1% SDS, pH
8.0) (40 mg/500 μl) with protease inhibitor cocktail (Roche Diagnostic, Germany) and suffi-
ciently homogenized on ice. To conduct an immnoprecipitation assay using APPsw/Ncad-CHO
cells, the cells were cultured in 6cm dishes at a density of 2.4 × 106 cells/dish and 48 hours after
incubation, the cells were transfected with the constructs. Then, the cells were washed twice in
PBS 24 hours after transfection, and scraped off. The cell pellets were suspended in TNE buffer
(10 mM Tris HCl, 150 mMNaCl, 1% NP-40, 1 mM EDTA, pH 7.8) supplemented with protease
inhibitor cocktail. Each sample was then centrifuged at 14,000 g for 20 minutes at 4°C, and the
supernatants were collected. Protein concentrations were determined using the Bradford assay
[27]. For the proteomic analysis, equal amounts of aliquots were treated with 20 μl protein
G-Sepharose (GE Healthcare, Sweden) for 1 hour at 4°C. After removing protein G-Sepharose
by centrifugation at 14,000 g for 20 minutes, 3 μg of monoclonal anti-BACE1 antibody (Chemi-
con, USA) was added to the supernatants. Each sample was rotated for 1 hour at 4°C, and then
treated with 40 μl protein G-Sepharose for 1 hour at 4°C. The immunoprecipitates were washed
with RIPA buffer 4 times, and resuspended in 20 μl 2 × sample buffer (125 mM Tris-HCl, 4%
SDS, 20% glycerol, 10% 2-mercaptoethanol, and 0.01% bromophenol blue, pH 6.8). After boil-
ing for 5 minutes and centrifuging at 14,000 g for 5 minutes, the supernatants were subjected to
SDS-PAGE. To visualize proteins, the gels were stained with silver nitrate using PlusOne Silver
Staining Kit, Protein (GE Healthcare). The protein bands were excised and subjected to in gel
trypsinization. Molecular mass analysis of the tryptic peptides was performed by MALDI-MS
with an ultrafleXtreme (Bruker Daltonics, Germany).
Antibodies
Mouse monoclonal anti-BACE1 antibody was from Chemicon. Rabbit polyclonal anti-BACE1
antibody was from Calbiochem (USA). Mouse monoclonal anti-clathrin heavy chain and rab-
bit polyclonal anti-Golgi-localized, gamma adaptin ear-containing, ARF-binding protein 1
(GGA1), goat polyclonal anti-HA tag antibodies were from Abcam (UK). Mouse monoclonal
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anti-Adaptin α antibody recognizing AP-2 α-subunit was from BD Transduction Laboratories
(USA). Mouse monoclonal anti-β-actin, rabbit polyclonal anti-APP C-terminus, mouse mono-
clonal anti-Aβ 6E10, rabbit polyclonal anti-HA tag antibodies were from SIGMA (USA). Rab-
bit polyclonal anti-myc tag antibody was fromMillipore (USA). Mouse monoclonal anti-myc
tag antibody was from Cell Signaling Technology (USA). Mouse monoclonal anti-transferrin
receptor (TfR) antibody was from Invitrogen (USA). Goat polyclonal anti-Early Endosome
Antigen 1 (EEA1), goat polyclonal anti-Lysosome-associated membrane protein 2 (Lamp2),
normal anti-mouse IgG and normal anti-rabbit IgG were from Santa Cruz Biotechnology, Inc
(USA). Alexa Fluor 546 mouse IgG, Alexa Fluor 488 mouse IgG, Alexa Fluor 405 mouse IgG,
Alexa Fluor 546 rabbit IgG, Alexa Fluor 488 rabbit IgG and Alexa Fluor 488 goat IgG antibod-
ies were obtained fromMolecular Probes (USA).
Plasmid constructs
The N-terminally myc-tagged WT BACE1 was a kind gift from Dr. Bradley Hyman (Massachu-
setts General Hospital, Harvard Medical School, USA) [28]. D495R BACE1, replacement from
aspartic acid at 495 to arginine, was generated fromWT BACE1 by site-directed mutagenesis
using the Quik Change site-directed mutagenesis kit (Agilent Technologies, USA). Primers:
5’-GCATGATGACTTTGCTCGTGACATCTCCCTGCTGA-3’ and 5’-TCAGCAGGGAGATGT
CACGAGCAAAGTCATCATGC-3’. Human AP-2 α-subunit was cloned by PCR from human
ovary cDNA (Gene Pool cDNA, Invitrogen) using these primers: 5’-TTTTGAATTCACCAAG
ATGCCGGCCGTGTCCAAG-3’ and 5’-TTTTCTCGAGAAACTGCGCTGAGAGCAATTCACA-
3’. The PCR product was inserted into the reading frame of the EcoR1/Xho1 sites of pcDNA 3
with HA tag vector, established by Dr. Ryosuke Takahashi (Kyoto University, Japan). Precise
cloning of all reading frames was verified by sequencing analysis.
Immunoblotting
For SDS-PAGE, the mice brains were extracted in RIPA buffer with protease inhibitor cocktail
and sufficiently homogenized on ice. Then, the samples were incubated for one night at 4°C.
Cultured cells were washed twice in PBS, and scraped off. The cell pellets were suspended in
TNE buffer supplemented with protease inhibitor cocktail. Each sample from mice brains or
cultured cells was then centrifuged at 14,000 g for 20 minutes at 4°C, and the supernatants
were collected. Protein concentration was determined using the Bradford assay. The following
protocol has been described previously [29, 30]. 4–12% NuPAGE Bis-Tris gel (Life technology)
was used to detect APP CTFβ. For Native-PAGE, the mice brains and cultured cells were
extracted in TNE buffer with protease inhibitor cocktail, followed by 10 times sonication. Each
sample from mice brains or cultured cells was then centrifuged at 14,000 g for 5 minutes at
4°C, and the supernatants were collected. Protein concentration was determined using the
Bradford assay. 20 μg samples were electrophoresed on 3–12% Native PAGE Bis-Tris Protein
Gels (Life technology) in anode buffer (0.1 M Tris HCl, pH 7.8), cathode buffer (0.068 M Gly-
cine, 0.053 M Tris HCl, pH 8.9). Then, the proteins on the gel were transferred to PVDF mem-
brane using Wet/Tank Blotting Systems (Bio-Rad) in Towbin buffer (Tris 3.0 g, Glycine 14.4 g,
methanol 150 ml/ 1L). The PVDF was stained by Panceau. The following protocol was the
same as that of SDS-PAGE. Signals on films were quantified with National Institutes of Health
Image software (Image J).
Immunostaining and internalization assay
APPsw/Ncad-CHO cells were harvested onto 0.1% polyethyleneimine-coated Lab-Tek II
Chamber Slides (Nalge Nunc International, USA) at a density of 1.0 × 105 /well and maintained
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in Opti-MEM containing 10% FBS for 24 hours. APPsw/Ncad-CHO cells were transfected
with each constructs and 24 hours after transfection, the cells were fixed with 4% paraformal-
dehyde for 20 minutes. The fixed cells were blocked with PBS containing 0.2% Triton X-100
for 15 minutes and incubated with primary antibodies for 1 hour. The cells were then incu-
bated with fluorescent-labelled second antibodies for 1 hour. To examine the internalizing pro-
cess of the cell surface BACE1, an internalization assay was conducted as described previously
[28]. Briefly, APPsw/Ncad-CHO cells were harvested onto 0.1% polyethyleneimine-coated
Lab-Tek II Chamber Slides at a density of 1.0 × 105 /well and maintained in Opti-MEM con-
taining 10% FBS for 24 hours. The cells were transfected with each constructs. 24 hours after
transfection, the cells were incubated with Opti-MEM containing an anti-myc antibody to
label the surface BACE1 for 1 hour at 4°C, and the cells were washed with ice cold PBS three
times. Then, the cells were returned to 37°C for indicated intervals, 0, 5 or 15 minutes. The
cells were fixed with 4% paraformaldehyde for 20 minutes. The fixed cells were blocked with
PBS containing 0.2% Triton X-100 for 15 minutes, and incubated with primary antibodies for
1 hour. The cells were then incubated with fluorescent-labelled second antibodies for 1 hour.
All images were visually analysed using a laser confocal scanning microscope, FV10i-LIV
(Olympus Corporation, Japan).
Measurement of extracellular sAPPβ and Aβ
The levels of Swedish sAPPβ, WT sAPPβ, Aβ 40 and Aβ 42 were measured by ELISA kits spe-
cific to Swedish sAPPβ, WT sAPPβ, Aβ 40 and Aβ 42 (Immuno-Biological Laboratories Co.,
Ltd., Japan), according to the manufacturer’s instructions. Briefly, APPsw/Ncad-CHO cells
were cultured in 3.5cm dishes at a density of 6.0 × 105 cells/well. SH-SY5Y cells were cultured
in 3.5cm dishes at a density of 1.2 × 106 cells/well. 24 hours after incubation, the cells were
transfected with the constructs. 24 hours after transfection, the cells were washed 2 times with
Opti-MEM and incubated with 1 ml of Opti-MEM. 9–12 hours after replacing the culture
medium, each medium was collected and centrifuged at 600 g for 5 minutes. 850 μl from the
supernatant was collected for ELISA samples. The level of sAPPβ was normalized by the
BACE1 level transiently overexpressed.
Biotinylation of cell surface proteins
APPsw/Ncad-CHO cells were cultured in 10cm dishes at a density of 3.0 × 106 cells/dish and
48 hours after incubation, the cells were transfected with the constructs. 24 hours after transfec-
tion, the cells were suspended in PBS containing Sulfo-NHS-LC-Biotin (Pierce Biotechnology,
USA) (0.3 mg/ml) for 30 minutes at 4°C. The cells were then washed with PBS and biotinylated
proteins were precipitated by 40 μl of streptoavidin agarose (Invitrogen) from equal amounts
of cell lysates. Precipitated biotinylated proteins were washed with TNE buffer 4 times and re-
suspended in 25 μl 2 × sample buffer. After boiling for 5 minutes and centrifuging at 14,000 g
for 5 minutes, the supernatants were then subjected to immunoblotting analysis.
Measurement of BACE1 activity
APPsw/Ncad-CHO cells were cultured in 3.5cm dishes at a density of 3.6 × 105 cells/well and
24 hours after incubation, they were transfected with the constructs. 24 hours after transfec-
tion, the cells were washed 2 times by PBS, collected, and lysed by adding 100 μl of Extraction
Buffer by pipetting 20 times. Then, BACE1 activity was measured by using β-secretase activity
kit (Abcam) according to the manufacturer’s protocol. Fluorescence was determined using
Infinite 200 PRO (Tecan Japan Co., Ltd., Japan) (excitation 345 nm, emission 505 nm).
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Statistical analysis
All values are given in means ± SE. Comparisons were performed using an unpaired Student’s
t-test. For comparison of multi-parametric analysis, one-way factorial ANOVA followed by
post-hoc analysis by Fisher Protected Least Significant Difference (PLSD) was used. p< 0.05
was considered to indicate a significant difference.
Results
HFD increased the amount of BACE1/clathrin complex in APP
transgenic mice
In a previous study, we observed that APP-CTFβ had accumulated in the brains of APP transgenic
mice fed with HFD for 20 weeks (APP-HFDmice), compared with that in the control APPmice.
Moreover, HFD did not affect on the levels of APP or BACE1, suggesting that HFDmay specifi-
cally strengthen BACE1 activity, thus promoting of the cleavage of APP by BACE1 [20]. To dem-
onstrate the mechanism through which HFD promotes BACE1-mediated APP cleavage, we set
out to identify the proteins that associate with BACE1 in mice fed with HFD. For this, lysates from
the brains of the control APPmice as well as those from APP-HFDmice were immunoprecipi-
tated with an anti-BACE1 antibody, and subjected to SDS-PAGE. The separated proteins were
visualized by silver staining, demonstrating a band density of around 180 kDa in the samples of
the APP-HFDmice stronger than that of the control APPmice (Fig 1A). The protein band was
identified by mass spectrometry as clathrin heavy chain. Clathrin heavy chain is a component of
clathrin vesicles; they form on the cell membrane and are associated with internalization of recep-
tors as well as ligands [31]. To confirm the complex formation of BACE1 with clathrin, fresh mice
brain lysates were immunoprecipitated with an anti-BACE1 antibody. Immunoblotting analysis
indicated that the amount of BACE1/clathrin complex in APP-HFDmice was greater than that in
the control APPmice (Fig 1B). Also, the level of clathrin in APP-HFDmice was not different from
that in the control APPmice (Fig 1C). These results indicated that HFDmight promote BACE1/
clathrin complex formation without changing the level of clathrin in APP transgenic mice.
AP-2 mediated the BACE1/clathrin complex formation in APP transgenic
mice
It has been previously reported that either the AP-2 complex (α-β2-μ2-σ2) [32, 33] or Golgi-
localized, gamma adaptin ear-containing, ARF-binding protein 1 (GGA1) [34] acts to mediate
the BACE1/clathrin complex formation. To reveal the mediator of BACE1/clathrin complex
formation in APP transgenic mice, brain lysates were immunoprecipitated with an anti-
BACE1 antibody. Immunoblotting analysis using an anti-AP-2α antibody indicated that
BACE1/AP-2 interaction was enhanced in APP-HFD mice relative to that in the control APP
mice (Fig 2A). To study the mechanistic link in these results, we examined the protein level of
AP-2, which was significantly higher in APP-HFD mice than that in the control APP mice (Fig
2B). On the other hand, immunoblotting analysis using an anti-GGA1 antibody indicated that
the amount of BACE1/GGA1 complex in APP-HFD mice was not different from that in the
control APP mice (Fig 2C). Moreover, the expression level of GGA1 in APP-HFD mice was the
same as that in the control APP mice (Fig 2D). In order to confirm the results from immuno-
precipitation assays, we also conducted Native-PAGE using anti-BACE1, anti-AP-2α, anti-
GGA1 and anti-clathrin antibodies. Immunoblotting analysis in the native condition showed
more BACE1-associating aggregates in the area between 242 kDa and 720 kDa in APP-HFD
mice compared to in the control APP mice. Importantly, these aggregates were not detected by
an anti-GGA1 antibody but clearly detected by an anti-AP-2α antibody. Many clathrin-
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associating aggregates were also observed in this area, both in APP-HFD mice and in the con-
trol APP mice (Fig 2E). These results indicated that AP-2 might mediate the BACE1/clathrin
complex formation in response to HFD in APP transgenic mice.
D495R BACE1 decreased the sAPPβ level
A recent report showed that AP-2 interacts with BACE1 at the first aspartate (D 495) residue
of the DDISLL sequence, while the artificial mutant D495R BACE1 inhibits the BACE1/AP-2
interaction [32]. First, to examine the effect of BACE1/AP-2/clathrin complex formation on
APP metabolism, we inhibited the trimeric complex formation by overexpressing D495R
BACE1 in Swedish APP overexpressing CHO cells. Immunostaining analysis indicated that
D495R BACE1 mainly localized at the plasma membrane. On the other hand, someWT
BACE1 localized at clathrin positive vesicles in the cytosolic region (Fig 3A). An immunopre-
cipitation assay confirmed that D495R mutation inhibited BACE1 interaction with AP-2 as
well as with clathrin (Fig 3B). An in vitro β-secretase activity assay indicated that the enzymatic
activity of D495R BACE1 in the artificial reaction buffer was not different from that of WT
BACE1, indicating that D495R mutation did not work as a dominant negative mutation on
BACE1 (Fig 3C). Importantly, ELISA indicated that the level of Swedish sAPPβ in D495R
BACE1-transfected cells was significantly lower than that in WT BACE1-transfected cells (Fig
3D), which was confirmed by examination of APP-CTFβ level by immunoblotting (Fig 3E).
Furthermore, the levels of extracellular Aβ 40 and Aβ 42 in D495R BACE1-transfected cells
were also significantly lower than those in WT BACE1-transfected cells (Fig 3F and 3G). In
order to examine whether the results from Swedish APP overexpressing CHO cells were rele-
vant to those of WT APP expressing neuronal cells, we investigated the role of BACE1/AP-2/
clathrin complex in SH-SY5Y cells. Interestingly, although it was not observed in the APP
overexpressing CHO cells (Fig 3E), the maturation of D495R BACE1 was significantly
Fig 1. HFD promoted BACE1/clathrin complex formation in APP transgenic mice. (A) Equal amounts of brain samples from 7–8 months age of the
control APPmice and APP-HFD mice (fed with HFD for 20 weeks) were immunoprecipitated by an anti-BACE1 antibody, and then SDS-PAGE was
conducted. As a negative control, samples were immunoprecipitated by a normal mouse IgG. To visualize proteins, the gels were stained with silver nitrate.
These proteomics assays were repeated twice using different four brain samples from the control APPmice as well as four samples from APP-HFDmice.
The band density around 180 kDa was significantly higher in APP-HFDmice than that in the control APPmice. The protein bands were excised and
subjected to in gel trypsinization, and molecular mass analysis of the tryptic peptides indicated that the band was clathrin heavy chain. (B) Equal amounts of
brain samples from 7–8 months age of the control APPmice and APP-HFDmice (fed with HFD for 20 weeks) were immunoprecipitated by a monoclonal anti-
BACE1 antibody (2nd row) and then they were immunoblotted by an anti-clathrin antibody or by an anti-BACE1 antibody. As a negative control, samples were
immunoprecipitated by a normal mouse IgG (top row). These immunoprecipitation assays were repeated twice using different four brain samples from the
control APPmice as well as four samples from APP-HFDmice. HFD promoted the BACE1/clathrin complex formation in APP transgenic mice. (C)
Immunoblotting analysis using an anti-clathrin antibody. Statistical analysis is shown in the bottom panel. The band density of the clathrin heavy chain was
normalized by that of β-actin. The band density of the control APPmice was regarded as 100% and that of APP-HFDmice was relatively indicated. The band
density of clathrin in APP-HFDmice (fed with HFD for 20 weeks) was the same as that in the control APPmice. n.s. indicates that there was no statistical
significance.
doi:10.1371/journal.pone.0131199.g001
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promoted compared to that of WT BACE1 in SH-SY5Y cells (Fig 3H). Since the maturation of
BACE1 is tightly associated with its proteolytic activity [35, 36], the levels of WT sAPPβ were
normalized by those of mature BACE1. Importantly, ELISA indicated that the level of WT
sAPPβ in D495R BACE1-transfected SH-SY5Y cells was significantly lower than that in WT
BACE1-transfected cells (Fig 3I). These results indicated that inhibition of BACE1/AP-2/cla-
thrin complex formation might down-regulate the β-site cleavage of APP, followed by decrease
in levels of sAPPβ, APP-CTFβ and Aβ.
Fig 2. AP-2 mediated BACE1/clathrin complex in APP transgenic mice. (A) Equal amounts of brain samples from 7–8 months age of the control APP
mice and APP-HFD mice (fed with HFD for 20 weeks) were immunoprecipitated by an anti-BACE1 antibody, and then immunoblotted by an anti-AP-2α
antibody (1st- 2nd lane). As a negative control, samples were immunoprecipitated by a normal mouse IgG (3rd- 4th lane). These immunoprecipitation assays
were repeated twice using different two brain samples from the control APPmice as well as two samples from APP-HFD mice. HFD promoted BACE1/AP-2/
clathrin complex formation. (B) Immunoblotting analysis using an anti-AP-2α antibody. Statistical analysis is shown in the bottom panel. The band density of
AP-2 was normalized by that of β-actin. The band density of the control APPmice was regarded as 100% and that of APP-HFD mice was relatively indicated.
The band density of AP-2 in APP-HFD mice (fed with HFD for 20 weeks) was significantly higher than that in the control APP mice (n = 4, p = 0.041). *
indicates p < 0.05. (C) Equal amounts of brain samples from 7–8 months age of the control APP mice and APP-HFDmice (fed with HFD for 20 weeks) were
immunoprecipitated by an anti-BACE1 antibody, and then immunoblotted by an anti-GGA1 antibody (1st- 2nd lane). As a negative control, samples were
immunoprecipitated by a normal mouse IgG (3rd- 4th lane). BACE1 and GGA1 formed complex in APP-HFDmice the same as in the control APP mice. (D)
Immunoblotting analysis using an anti-GGA1 antibody. Statistical analysis is shown in the bottom panel. The band density of GGA1 was normalized by that of
β-actin. The band density of the control APP mice was regarded as 100% and that of APP-HFDmice was relatively indicated. The band density of GGA1 in
APP-HFDmice (fed with HFD for 20 weeks) was the same as that in the control APPmice (n = 3). n.s. indicates that there was no statistical significance. (E)
Immunoblotting analysis in the native condition. Equal amounts of brain samples from 7–8 months age of the control APPmice (n = 3) and APP-HFDmice
(fed with HFD for 20 weeks) (n = 3) were separated on Native-PAGE gel, followed by detection using anti-BACE1 (1st panel), anti-AP-2α (2nd panel), anti-
GGA1 (3rd panel) and anti-clathrin antibodies (4th panel). The band density in the area from 242 kDa to 720 kDa (white rectangle) was normalized by the
density of Panceau, and statistical analysis is shown in the right panel. The band density of the control APPmice (sample 1) was regarded as 100% and that
of other mice was relatively indicated. The band density of BACE1 in the area from 242 kDa to 720 kDa did not match that of GGA1 but clearly matched that
of AP-2 in each sample. The average band densities of BACE1 (p = 0.038) as well as AP-2 (p = 0.041) in the area from 242 kDa to 720 kDa in APP-HFDmice
were higher than those in the control APPmice.
doi:10.1371/journal.pone.0131199.g002
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Fig 3. D495R BACE1 inhibited the cleavage of APP in Swedish APP overexpressing CHO cells and in SH-SY5Y cells. (A) Immunostaining analysis to
examine the localizations of BACE1 and clathrin using an anti-myc antibody (2nd lane) and an anti-clathrin antibody (3rd lane). APPsw/Ncad-CHO cells were
transfected either with WT BACE1 (middle row) or with D495R BACE1 (bottom row). Myc tag was linked to these BACE1 constructs. As a negative control,
the cells were overexpressing empty vector (top row). The nucleus of the cell was labelled by DAPI (1st lane). High-magnification images are shown in the 5th
lane. WT BACE1 was co-localized with clathrin in the cytoplasmic vesicles (arrowhead). On the other hand, D495R BACE1 was localized on the plasma
membrane and hardly co-localized with clathrin. Scale bar indicates 10 μm. (B) APPsw/Ncad-CHO cells were transfected either with WT BACE1 (1st and 3rd
lanes) or with D495R BACE1 (2nd lane). Myc tag was linked to these BACE1 constructs. Equal amounts of cell lysates were immunoprecipitated by an anti-
myc antibody, and then immunoblotted by an anti-clathrin antibody (upper panel, 1st row), an anti-AP-2α antibody (2nd row) and an anti-myc antibody (3rd
row). As a negative control, samples were immunoprecipitated by a normal rabbit IgG (3rd lane). To confirm these results, samples were immunoprecipitated
by an anti-clathrin antibody and immunoblotted by an anti-myc antibody (4th row) or by an anti-clathrin antibody (5th row). The expression levels of each
protein in cell lysates are shown in the bottom panel. The level of BACE1/AP-2/clathrin complex was decreased in D495R BACE1 expressing cells compared
with in WT BACE1 cells. (C) APPsw/Ncad-CHO cells were transfected either with WT BACE1 (1st, 3rd and 4th lanes) or with D495R BACE1 (2nd lane). These
cells were lysed, and β-secretase activity in the cell lysates was measured by the β-secretase activity assay kit. All values were subtracted from the
background readings obtained from only substrate (without secretase) (4th lane). As a negative control, the CHO cells transfectedWT BACE1 were treated
with the BACE1 inhibitor which was included in the kit (3rd lane). As a positive control, the substrate was mixed with the recombinant active BACE1which was
also included in the kit (5th lane). In vitro condition, the BACE1 activity in D495R BACE1 transfected cell was not different from that in WT BACE1 (n = 12, F
(4,31) = 32.48). n.s. indicates that there was no statistical significance. (D) APPsw/Ncad-CHO cells were transfected either with WT BACE1 (1
st lane) or with
D495R BACE1 (2nd lane). The levels of extracellular Swedish sAPPβ were determined by the Swedish sAPPβ specific ELISA kit. The levels of sAPPβ were
normalized by the levels of BACE1 (mature plus immature forms) transiently overexpressed. The average level of sAPPβ in WT BACE1-transfected cells
was regarded as 100% and that in D495R BACE1-transfected cells was relatively indicated. The level of Swedish sAPPβ in D495R BACE1-transfected cell
was significantly smaller than that in WT BACE1 (n = 12, p = 0.034). * indicated p < 0.05. (E) Immunoblotting analysis using an anti-Aβ 6E10 antibody which
only detects APP-CTFβ. APPsw/Ncad-CHO cells were transfected either with WT BACE1 (1st lane) or with D495R BACE1 (2nd lane). The maturation of WT
BACE1 was not different with that of D495R BACE1. Although the band density of APP full length was not different, the band density of APP-CTFβ in D495R-
transfected cells was significantly lower than that in WT BACE1 (n = 5, p = 0.009). * indicated p < 0.05. (F) APPsw/Ncad-CHO cells were transfected either
with WT BACE1 (1st lane) or with D495R BACE1 (2nd lane). The levels of extracellular Aβ 40 were determined by the Aβ 40 specific ELISA kit. The average
level of Aβ 40 in WT BACE1-transfected cells was regarded as 100% and that in D495R BACE1-transfected cells was relatively indicated. The level of
Swedish Aβ 40 in D495R BACE1-transfected cell was significantly smaller than that in WT BACE1 (n = 12, p = 0.037). * indicated p < 0.05. (G) APPsw/Ncad-
CHO cells were transfected either with WT BACE1 (1st lane) or with D495R BACE1 (2nd lane). The levels of extracellular Aβ 42 were determined by the Aβ 42
HFD Promotes BACE1/AP-2/Clathrin Complex Formation
PLOS ONE | DOI:10.1371/journal.pone.0131199 September 28, 2015 9 / 16
Overexpression of AP-2 increased the sAPPβ level
Next, we promoted the formation of the BACE1/AP-2/clathrin complex by AP-2 overexpres-
sion in Swedish APP overexpressing CHO cells. An immunoprecipitation assay using an anti-
clathrin antibody indicated that overexpression of AP-2 increased the amount of BACE1/cla-
thrin complex (Fig 4A). We also conducted a biotinylation assay, demonstrating that overex-
pression of AP-2 decreased the cell surface level of BACE1 (Fig 4A). Similarly, the
overexpression of AP-2 decreased the cell surface level of Transferrin receptor (TfR), which is
endocytosed by AP-2/clathrin vesicle [37]. Immunostaining analysis also showed that AP-2
overexpression reduced the cell surface level of BACE1 (Fig 4B). BACE1 was co-localized with
Early Endosome Antigen 1 (EEA1); an endosome marker, and also with Lysosome-associated
membrane protein 2 (Lamp2); a lysosome marker under AP-2 overexpressing conditions (Fig
4C). Moreover, in order to observe the internalization of cell surface BACE1, we conducted an
internalization assay by labeling cell surface BACE1 with an anti-myc antibody. In the empty
vector-transfected cells, anti-myc antibody-labeled BACE1 was observed both on the cell mem-
brane and at the intracellular vesicles 15 minutes after incubation. On the other hand, in the
AP-2 overexpressing cells, anti-myc antibody-labeled BACE1 was clearly accumulated in the
intracellular compartment while it was hardly observed on the cell membrane (Fig 4D). During
the internalizing process (5 minutes after incubation), BACE1 formed a complex with AP-2
and clathrin (Fig 4E). Interestingly, anti-myc labeled BACE1 did not completely co-localize
with APP 15 minutes after incubation, but APP remarkably localized around the region
BACE1 was accumulated (Fig 4F). ELISA indicated that overexpression of AP-2 significantly
increased sAPPβ level in Swedish APP overexpressing CHO cells. On the other hand, D495R
BACE1 suppressed the level of sAPPβ under AP-2 overexpressing conditions (Fig 4G). As well
as in the APP overexpressing CHO cells, overexpression of AP-2 significantly increased the
sAPPβ level in SH-SY5Y cells, and it was rescued by the expression of D495R BACE1 (Fig 4H).
These results indicated that enhancement of the BACE1/AP-2/clathrin complex formation
might accelerate the internalization of cell surface BACE1, followed by promotion of the APP
cleavage by BACE1.
Discussion
A recent population-based twin study reported that mid-life obesity increases the risk of late-
life AD [38]. Moreover, a Japanese cohort Hisayama study indicated that individuals with type
2 diabetes develop deposits of Aβ [39]. As such, obesity and type 2 diabetes are highlighted as
risk factors of AD. There are many experimental studies showing that HFD exacerbates Aβ
deposition in several strains of APP transgenic mice [16–20]. As a mechanism, it was reported
that HFD regulates γ-secretase activity [17]. In our previous report, it was stated that HFD
increases the level of APP-CTFβ without promoting a change in the level of BACE1. Therefore,
we hypothesized that HFD may strengthen the activity of BACE1, followed by promotion of
the cleavage of APP [20]. The present study aims to understand how HFD enhances the
specific ELISA kit. The average level of Aβ 42 in WT BACE1-transfected cells was regarded as 100% and that in D495R BACE1-transfected cells was
relatively indicated. The level of Swedish Aβ 42 in D495R BACE1-transfected cell was significantly smaller than that in WT BACE1 (n = 12, p = 0.003). *
indicated p < 0.05. (H) Immunoblotting analysis using an anti-myc antibody. SH-SY5Y cells were transfected either with WT BACE1 (1st lane) or with D495R
BACE1 (2nd lane). The maturation was analysed by the relative ration of the mature form of BACE1/the immature form of BACE1. The maturation of D495R
BACE1 was significantly promoted compared to that of WT BACE1 (n = 6, p = 0.0001). * indicates p < 0.05. (I) SH-SY5Y cells were transfected either with
WT BACE1 (1st lane) or with D495R BACE1 (2nd lane). The levels of extracellular WT sAPPβwere determined by the WT sAPPβ specific ELISA kit. The
levels of sAPPβ were normalized by the levels of BACE1 (mature form) transiently overexpressed. The average level of sAPPβ in WT BACE1-transfected
cells was regarded as 100% and that in D495R BACE1-transfected cells is relatively indicated. The level of WT sAPPβ in D495R BACE1-transfected cell was
significantly smaller than that in WT BACE1 (n = 15, p = 0.0007). * indicates p < 0.05.
doi:10.1371/journal.pone.0131199.g003
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Fig 4. Overexpression of AP-2 promoted the cleavage of APP by BACE1 in Swedish APP overexpressing CHO cells and in SH-SY5Y cells. (A)
APPsw/Ncad-CHO cells were transfected either with WT BACE1 and empty vector (1st and 3rd lanes) or with WT BACE1 and AP-2α (2nd and 4th lanes). Myc
tag was linked to WT BACE1 and HA tag was linked to AP-2α. Equal amounts of cell lysate were immunoprecipitated by an anti-clathrin antibody, and then
immunoblotted by an anti-myc antibody (upper panel, 1st and 2nd lanes). As a negative control, samples were immunoprecipitated by a normal mouse IgG
(3rd and 4th lanes). The CHO cells overexpressing either with WT BACE1 and empty vector or with WT BACE1 and AP-2α were biotinylated, and cell surface
level of BACE1 was examined by an anti-myc antibody (middle panel, 1st row). As a positive control, cell surface level of TfR was examined (middle panel,
2nd row). The expression levels of each protein in cell lysates are shown in the bottom panel. Overexpression of AP-2 increased the amount of BACE1/
clathrin complex, and decreased the cell surface level of BACE1. (B) Immunostaining analysis to examine the localizations of BACE1 using an anti-myc
antibody under AP-2 overexpressing conditions. APPsw/Ncad-CHO cells were transfected with WT BACE1 and AP-2α (right panel). As a negative control,
the cells were overexpressing WT BACE1 and empty vector (left panel). Myc tag was linked to WT BACE1. WT BACE1 was localized on the cell surface
(arrowhead) as well as in the intracellular compartments in a negative control cells. On the other hand, WT BACE1was hardly localized on the plasma
membrane and mainly localized in the intracellular compartments under AP-2 overexpressing conditions. Scale bar indicates 10 μm. (C) Immunostaining
analysis to examine the detailed localizations of BACE1 using anti-EEA1 and anti-Lamp2 antibodies under AP-2 overexpressing conditions. Myc tag was
linked to WT BACE1. EEA1 was used as an endosome marker and Lamp2 was a lysosomemarker. Under the AP-2 overexpressing condition, WT BACE1
was localized in the endosome and in the lysosome. (D) An internalization assay to examine the localization change of cell surface BACE1. APPsw/Ncad-
CHO cells were transfected with WT BACE1 and empty vector (left panel) or with WT BACE1 and AP-2α (right panel). The cell surface BACE1 was labeled
by an anti-myc antibody, followed by examination of its localization before (upper row) and 15 minutes after incubation (middle row). The expression of AP-2α
was checked by an anti-HA antibody (bottom row). 15 minutes after incubation, the BACE1 labelled by an anti-myc antibody was observed on the cell
membrane (arrowhead) and at the intracellular vesicles (arrow) in empty vector-transfected cells. On the other hand, the BACE1 was clearly accumulated in
the intracellular compartment (arrow) and it was hardly observed on the cell membrane in the AP-2 overexpresing cells. (E) Triple immunostaining analysis
for detecting BACE1/AP-2/clathrin complex in the internalization assay. APPsw/Ncad-CHO cells were transfected with WT BACE1 and AP-2α. Cell surface
BACE1 was labelled by an anti-myc antibody. Clathrin and AP-2 were stained with anti-clathrin and anti-HA antibodies respectively. BACE1/AP-2/clathrin
complex formed during the internalization of cell surface BACE1 (5 minutes after incubation) is indicated arrow. Right upper panel is a merged image and
right bottom panel is high magnification of the image contained in the rectangle in the upper panel. Scale bar indicates 10 μm. (F) Immunostaining analysis to
examine whether the internalized BACE1 co-localized with APP under AP-2 overexpressing conditions. Myc tag was linked to WT BACE1. The cell surface
BACE1 was labelled by an anti-myc antibody, followed by incubating for 15 minutes. APP was stained by 6E10 antibody. 15 minutes after incubation, the
BACE1 labelled by an anti-myc antibody was not clearly co-localized with APP. On the other hand, APP remarkably surrounded the compartment in which
the BACE1 was accumulated. Scale bar indicates 10 μm. (G) APPsw/Ncad-CHO cells were transfected with WT BACE1 and empty vector (1st lane), with WT
BACE1 and AP-2α (2nd lane) or with D495R BACE1 and AP-2α (3rd lane). The levels of extracellular Swedish sAPPβwere determined by the Swedish
sAPPβ specific ELISA kit. The levels of sAPPβ were normalized by the levels of BACE1 (mature form plus immature) transiently overexpressed. The
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cleavage of APP by BACE1. Here we demonstrate that HFD increased the amount of BACE1/
AP-2/clathrin complex in APP transgenic mice (Figs 1 and 2). In both Swedish APP overex-
pressing CHO cells and SH-SY5Y cells, promotion of the trimeric complex formation increased
the sAPPβ level (Fig 4). On the other hand, inhibition of the complex formation decreased the
level of sAPPβ (Fig 3). Therefore, we concluded that HFD might increase the amount of
BACE1/AP-2/clathrin complex, followed by enhancement of β-site cleavage of APP in APP
transgenic mice.
In APP transgenic mice, HFD did not change the level of clathrin (Fig 1) or BACE1 [20].
However, HFD increased the level of AP-2, and drastically enhanced the interaction of BACE1
with AP-2 (Fig 2). In Swedish APP overexpressing CHO cells, overexpression of AP-2
increased the amount of the BACE1/AP-2/clathrin complex (Fig 4). Therefore, we speculated
that HFD-induced increase of AP-2 level was the trigger for the BACE1/AP-2/clathrin complex
formation in APP transgenic mice. Some reports showed that APP is cleaved by BACE1 in the
trans-Golgi network [40, 41] or on the cell surface [42]. However, other reports claimed that
the cleavage occurs in the endosomes [28, 43, 44]. In the present study, due to the lack of inter-
action with AP-2, D495R BACE1 mainly localized at the cell surface (Fig 3) and AP-2 overex-
pression reduced the cell surface level of BACE1 in the APP overexpressing CHO cells (Fig 4).
Moreover, the internalization of BACE1 was clearly promoted under AP-2 overexpressing con-
ditions (Fig 4). Although our present study could not clearly identify the compartment in
which BACE1 primarily cleaves APP, these results suggested that the BACE1/AP-2/clathrin
complex formation might lead to transportation of BACE1 from the cell surface to the intracel-
lular compartments, which might promote the cleavage of APP by BACE1. In this sense, the
AP-2/clathrin-induced endocytosis of BACE1 might be a key step of the HFD-promoted APP
cleavage by BACE1 in APP transgenic mice.
Consistent with our results, a paper suggesting that knockdown of dynamin 1, which inhib-
its the clathrin-mediated endocytosis, down-regulates BACE1 internalization from the cell sur-
face, and inhibits the cleavage of APP by BACE1 [45]. Dynamin 1 and AP-2 are differently
involved in the clathrin-mediated endocytosis. Dynamin 1 principally undergoes the fission of
newly formed clathrin-coated vesicle from the cell membrane. On the other hand, AP-2 links
clathrin to molecules (i.e. BACE1) in the vesicles. Our data showed that the D495R mutation
on BACE1, which inhibits interaction with AP-2, clearly increased the amount of cell surface
BACE1 (Fig 3), indicating that AP-2 and dynamin 1 may independently regulate BACE1 traf-
ficking as well as the cleavage of APP. Moreover, HFD did not affect on the expression level of
dynamin 1 in APP transgenic mice (data not shown). Therefore, we proposed that HFD may
not affect on dynamin 1-regulated BACE1 trafficking. Another study also demonstrated that
the AP-2/clathrin-mediated BACE1 internalization enhances the cleavage of APP by BACE1.
As a mechanism, the internalized BACE1 may cleave the internalized APP in the early endo-
some, or it may cleave the newly synthesised APP in the trans-Golgi network [33]. There is,
however, a report inconsistent with ours, stating that the AP-2/clathrin-mediated BACE1
endocytosis does not affect on the APP cleavage [32]. Although the reason for the discrepancy
average level of sAPPβ in WT BACE1 with empty vector-transfected cells was regarded as 100% and that in other cells was relatively indicated. The level of
Swedish sAPPβ in WT BACE1 and AP-2α-transfected cell was significantly higher than that in WT BACE1 and empty vector (n = 12, F (2,33) = 7.86,
p = 0.001). On the other hand, the level in D495R BACE1 and AP-2α-transfected cell was lower than that in WT BACE1 and AP-2α-transfected cell
(p = 0.002). * indicates p < 0.05. (H) SH-SY5Y cells were transfected with WT BACE1 and empty vector (1st lane), with WT BACE1 and AP-2α (2nd lane) or
with D495R BACE1 and AP-2α (3rd lane). The levels of extracellular WT sAPPβwere determined by the WT sAPPβ specific ELISA kit. The levels of sAPPβ
were normalized by the levels of BACE1 (mature form) transiently overexpressed. The average level of sAPPβ in WT BACE1 with empty vector-transfected
cells was regarded as 100% and that in other cells was relatively indicated. The level of WT sAPPβ in WT BACE1 and AP-2α-transfected cell was
significantly higher than that in WT BACE1 and empty vector (n = 14, F (2,39) = 6.34, p = 0.045). On the other hand, the level in D495R BACE1 and AP-2α-
transfected cell was lower than that in WT BACE1 and AP-2α-transfected cell (p = 0.001). * indicates p < 0.05.
doi:10.1371/journal.pone.0131199.g004
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between their results and ours is unclear, we speculate that it might at least be due to differ-
ences in experimental design. In our study, we used CHO cells stably overexpressing Swedish
APP or native SH-SY5Y cells, whereas their study utilized neuroglioma-derived H4 cells or rat
cortical neurons transiently overexpressing WT APP with artificial mutations inhibiting the
cleavage by α-secretase and caspase. As shown in Fig 3, although WT BACE1 and D495R
BACE1 were matured in the same way in CHO cells, the maturation of D495R BACE1 was sig-
nificantly promoted compared to that of WT BACE1 in SH-SY5Y cells. We identified a signifi-
cant decrease in the level of sAPPβ by normalizing its level with the “mature BACE1” level (Fig
3), but it was not identified when we normalized sAPPβ level with the “total (immature
+ mature) BACE1” level in SH-SY5Y cells (WT BACE1 100% ± 3.83 vs. D495R BACE1 98.1%
± 4.27, data not shown). Therefore, the difference of BACE1 maturation among cell types
might lead to this discrepancy. In addition, the decreased level of sAPPβ by D495R BACE1 in
the APP overexpressing CHO cells was greater than that in SH-SY5Y cells (Fig 3). Since Swed-
ish APP generates a significantly larger increase in Aβ production in the endocytic compart-
ment [28, 46], the different property in APP might also be the reason for the discrepancy.
There is a limitation in the present study. We could not determine whether or not HFD had
an effect on APP trafficking. Due to difficulties in labelling the cell surface APP by two different
antibodies; 6E10 and 22C11 which are against N-terminus of APP (data not shown), we could
not make clear the effect of AP-2 on APP trafficking. A previous paper showed that AP-2 inter-
acts with APP on its C-terminal region [47]. Also, AP-2 knockdown clearly increases the
expression level of APP [32]. These reports are suggesting that AP-2 can modulate not only
BACE1 but also APP trafficking. Nevertheless, considering that obesity and type 2 diabetes are
risk factors of “sporadic” AD, we should examine the effect of the BACE1/AP-2/clathrin com-
plex on the pathology of sporadic AD in future studies. We identified the trimeric complex in
the sporadic human AD brain by immunoprecipitation analysis (unpublished observation).
We demonstrated for the first time a detailed mechanism of how HFD promotes APP process-
ing by regulating BACE1 trafficking. As displayed in Fig 5, we demonstrated that HFD pro-
moted the BACE1/AP-2/clathrin complex formation, followed by transportation of BACE1
Fig 5. Schematic presentation of events under HFD conditions. HFD promotes the BACE1/AP-2/clathrin complex formation by increasing AP-2 levels,
which accelerates the trafficking of BACE1 from the cell surface to intracellular compartments. The change in BACE1 trafficking enhances β-site APP
cleavage in APP transgenic mice.
doi:10.1371/journal.pone.0131199.g005
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from the cell surface to intracellular compartments. These events promoted the BACE1-me-
diated APP cleavage in APP transgenic mice. So far, it is widely considered that HFD interferes
with insulin signalling and/or diabetic conditions, which may affect neuronal functions. We
propose that HFD may regulate BACE1 function, which is associated with the exacerbation of
Aβ pathology. Thus, a molecular link between dietary condition and Aβ pathology is important
for the prevention of AD.
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